ASCO/ESMO 2020 - The Future of Head and Neck Cancer Treatment

ASCO/ESMO 2020 - Head and Neck Cancer Updates - JAVELIN100 Trial UpdateПодробнее

ASCO/ESMO 2020 Debio 1143/ Xevinapant Study UpdateПодробнее

Curative Modalities & Immunotherapy for Head & Neck Cancer - 2021 ASCO ESMO Head & Neck RecapПодробнее

HPV and Head and Neck Cancers - 2021 ASCO ESMO Head & Neck RecapПодробнее

ASCO/ESMO 2020 - KEYNOTE 048 Study Update, What Have We Learned?Подробнее

ASCO/ESMO 2020 PembroRAD Trial UpdateПодробнее

Recent Data, Developments in Palliative Cancer Treatments - 2021 ASCO ESMO Head & Neck RecapПодробнее

ASCO 2024 Top 3 Practice Changing Head & Neck Cancer StudiesПодробнее

The future role of immunotherapy in head and neck cancersПодробнее

Improving head and neck cancer management post-COVIDПодробнее

MAP 2024: shaping the future of precision oncologyПодробнее

Update on Head and Neck Cancer from ASCO 2020Подробнее

Palliative Care and Studies for Incurable Head and Neck Cancers - 2021 ASCO ESMO Head & Neck RecapПодробнее

ASCO Town Hall on Head & Neck Cancers 06-25-2020Подробнее

Future directions for head and neck cancerПодробнее

Yungan Tao, ESMO 2018 – Treatment of locally advanced head and neck squamous cell carcinomasПодробнее

Dr. Saba on the Future of Head and Neck Cancer TreatmentПодробнее

Immunotherapy Treatments in Patients with Head and Neck Cancer - ASCO Recaps Head and Neck CancerПодробнее

Novel findings in the treatment and disease biology of head and neck cancers at ESMO 2023Подробнее